When are observational studies as credible as randomised trials?

Lancet

Volumn 363, Issue 9422, 2004, Pages 1728-1731

  Vandenbroucke, Jan P ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CASE CONTROL STUDY; CLINICAL TRIAL; CONSULTATION; CONTROLLED CLINICAL TRIAL; GENETICS; HUMAN; MEDICAL PRACTICE; MEDICAL RESEARCH; METHODOLOGY; OBSERVATION; PHYSICIAN; POPULATION GENETIC PARAMETERS; PRESCRIPTION; PRIORITY JOURNAL; PROGNOSIS; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RESEARCH SUBJECT; REVIEW; STATISTICAL CONCEPTS; TREATMENT OUTCOME;

EID: 2442649987     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16261-2     Document Type: Note

References (21)

1. Schulz KF, Grimes DA. Allocation concealment in randomised trials: defending against deciphering. Lancet. 359:2002;614-618
2. Fisher RA. The design of experiments. 8th edn, 1971. Reprinted: Bennet JH, ed. Statistical methods, experimental design, and scientific inference. Oxford: Oxford University Press, 1995.
3. Fisher RA. The design of experiments. 8th edn, 1971. Reprinted: Bennet JH, ed. Statistical methods, experimental design, and scientific inference. Oxford: Oxford University Press, 1995.
4. Chalmers I. Why transition from alternation to randomisation in clinical trials was made. BMJ. 319:1999;1372
5. Jick H, Vessey MP. Case-control studies of drug induced illness. Am J Epidemiol. 107:1978;1-7
6. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet. 346:1995;1589-1593
7. Miettinen OS. The need for randomization in the study of intended effects. Stat Med. 2:1983;267-271
8. Rubin DB. Bayesian inference for causal effects: the role of randomization. Ann Statistics. 6:1978;34-58
9. Rosenbaum PR, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 70:1983;41-55
10. Rosenbaum PR. Observational studies. 2nd edn:2002;Springer, New York
11. Smith GD, Ebrahim S. 'Mendelian randomization': can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol. 32:2003;1-22
12. Little J, Khoury MJ. Mendelian randomisation: a new spin or real progress? Lancet. 362:2003;930-931
13. Goldthorpe JH. Causation, statistics and sociology. Eur Sociol Rev. 17:2001;1-20
14. Miettinen OS. Theoretical epidemiology: principles of occurrence research in medicine. 1985;44 Wiley, New York
15. Beral V, Banks E, Reeves G. Evidence from randomised trials on the long-term effects of hormone replacement therapy. Lancet. 360:2002;942-944
16. The Million Women Study. Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000. BJOG. 109:2002;1319-1330
17. Breslow NE, Day NE. Statistical methods in cancer research. Vol II. The design and analysis of cohort studies. Lyon: World Health Organization, 1987: 17-20.
18. Kunz R, Oxman AD. The unpredictability paradox: review of empirical comparisons of randomised and non-randomised clinical trials. BMJ. 317:1998;1185-1190
19. Lagaaij EL, Hennemann IP, Ruigrok M, et al. Effect of one-HLA-DR-antigen-matched and completely HLA-DR-mismatched blood transfusions on survival of heart and kidney allografts. N Engl J Med. 321:1989;701-705
20. Smets YF, Westendorp RG, van der Pijl JW, et al. Effect of simultaneous pancreas-kidney transplantation on mortality of patients with type-1 diabetes mellitus and end-stage renal failure. Lancet. 353:1999;1915-1919
21. Darby S, McGale P, Peto R, Granath F, Hall P, Ekbom A. Mortality from cardiovascular disease more than 10 years after radiotherapy for breast cancer: nationwide cohort study of 90 000 Swedish women. BMJ. 326:2003;256-257